PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsLaboratoires SMB
Laboratoires SMB
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
PravafenixFenofibrate, Pravastatin2011-04-142024-2033
Hypercholesterolemia
,
Coronary artery disease
,
Dyslipidemias
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
,
Periodontal diseases
,
Infectious skin diseases
,
Gram-negative bacterial infections
,
Oral candidiasis
,
Gram-positive bacterial infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Retinol
breast neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
healthy volunteers/patients
,
adenocarcinoma
,
stomach neoplasms
,
esophageal neoplasms
,
rectal neoplasms
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
uveitis
,
sigmoid neoplasms
,
mucinous adenocarcinoma
,
colonic neoplasms
,
cystadenocarcinoma
,
psoriasis
,
leukemia
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
colorectal neoplasms
,
neoplasms
,
rheumatoid arthritis
,
arthritis
,
pulmonary embolism
,
embolism
,
atrial fibrillation
,
thrombosis
,
venous thrombosis
,
carcinoma
,
liver neoplasms
,
pancreatic neoplasms
,
thromboembolism
,
prostatic neoplasms
,
gastrointestinal neoplasms
,
lung neoplasms
,
neuroendocrine tumors
,
carcinoid tumor
,
paraneoplastic syndromes
,
islet cell adenoma
,
malignant carcinoid syndrome
,
chronic kidney disease-mineral and bone disorder
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
hepatocellular carcinoma
,
neurotoxicity syndromes
,
drug therapy
,
neoplasm metastasis
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
dyslipidemias
,
osteoporosis
,
spinal fractures
,
kidney transplantation
,
venous thromboembolism
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use